Skip to main content
Erschienen in: Osteoporosis International 3/2006

01.03.2006 | Original Article

Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy

verfasst von: Viktoria Ferencz, Szilvia Meszaros, Emoke Csupor, Edit Toth, Katalin Bors, Andras Falus, Csaba Horvath

Erschienen in: Osteoporosis International | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Our aim was to investigate whether pollen-allergy can affect bone mass and fractures in postmenopausal women.

Methods

A total of 125 postmenopausal pollen-allergic women (mean age: 61.26 yr) were split into four groups: (1) treated with neither H1 histamine receptor (H1R) antagonist nor inhaled corticosteroid (n=43); (2) treated only with H1R antagonist (n=53); (3) treated with both H1R antagonist and inhaled corticosteroid (n=17); (4) treated with only inhaled corticosteroid (n=12). Treatment, in the appropriate groups, had occurred for at least 5 years, seasonally. One-hundred non-allergic postmenopausal subjects matched for age, body mass index (BMI), and age at menopause served as controls.

Results

Overweight and obesity (25 kg/m2≤BMI) were common among the allergic women (76%). Allergic patients without treatment had a slightly lower bone density than their non-allergic counterparts. The rate (34.9%) of prevalent low-energy fractures (distal forearm, hip, and clinical vertebral fractures) in untreated allergic patients was almost triple that observed in non-allergic women (13%, chi2 p=0.003). Bone fracture occurred more often in H1R-only treated patients (30.19%) than in controls (chi2 p=0.01); however, clinical vertebral or hip fractures developed neither in those treated only with H1R antagonist nor in those who received both H1R antagonist and inhaled corticosteroid. Bone fractures were more frequent among patients with inhaled steroid treatment than among patients with a combined treatment of inhaled steroid and antihistamine (50 versus 29.4%). BMI predicted prevalent fractures at 1.278 (95% CI: 1.047–1.559, p=0.016) for a 1 kg/m2 increase among untreated allergic patients.

Conclusion

In conclusion, we found a high prevalence of low-energy fractures among pollen-allergic postmenopausal women which was associated with obesity. It is possible that the H1R antagonists compensate for both the negative effect of pollen-allergy and the adverse effect of inhaled corticosteroid treatment on bone fracture risk.
Literatur
1.
Zurück zum Zitat McKenna MJ, Frame B (1985) The mast cell and bone. Clin Ortop 200:226–233PubMed McKenna MJ, Frame B (1985) The mast cell and bone. Clin Ortop 200:226–233PubMed
2.
Zurück zum Zitat Feik SA, Storey E (1979) Low-calcium/high phosphorus rickets in rats. Mast cell changes. Pathology 11:641–652PubMedCrossRef Feik SA, Storey E (1979) Low-calcium/high phosphorus rickets in rats. Mast cell changes. Pathology 11:641–652PubMedCrossRef
3.
Zurück zum Zitat de Gennes C, Kuntz D, de Vernejoul MC (1992) Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop 279:281–291 de Gennes C, Kuntz D, de Vernejoul MC (1992) Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop 279:281–291
4.
Zurück zum Zitat Dobigny C, Saffar JL (1997) H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model. J Cell Physiol 173:10–18PubMedCrossRef Dobigny C, Saffar JL (1997) H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model. J Cell Physiol 173:10–18PubMedCrossRef
5.
Zurück zum Zitat Nakamura M, Kuroda H, Narita K, Endo Y (1996) Parathyroid hormone induces a rapid increase in the number of active osteoclasts by releasing histamine from mast cells. Life Sci 58:1861–1868PubMedCrossRef Nakamura M, Kuroda H, Narita K, Endo Y (1996) Parathyroid hormone induces a rapid increase in the number of active osteoclasts by releasing histamine from mast cells. Life Sci 58:1861–1868PubMedCrossRef
6.
Zurück zum Zitat Deyama Y, Kikuiri T, Ohnishi G, Feng YG, Takeyama S, Hatta M, Yoshimura Y, Suzuki K (2002) Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-kappaB ligand by osteoblasts. Biochem Biophys Res Commun 298:240–246PubMedCrossRef Deyama Y, Kikuiri T, Ohnishi G, Feng YG, Takeyama S, Hatta M, Yoshimura Y, Suzuki K (2002) Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-kappaB ligand by osteoblasts. Biochem Biophys Res Commun 298:240–246PubMedCrossRef
7.
Zurück zum Zitat Klein I, Lehotay DC, Watson CG, Rogerson B, Levey GS (1981) Human parathyroid adenoma adenylate cyclase: stimulation by histamine that is blocked by cimetidine. Metabolism 30:635–637PubMedCrossRef Klein I, Lehotay DC, Watson CG, Rogerson B, Levey GS (1981) Human parathyroid adenoma adenylate cyclase: stimulation by histamine that is blocked by cimetidine. Metabolism 30:635–637PubMedCrossRef
8.
Zurück zum Zitat Brumsen C, Papapoulos SE, Lentjes EG, Kluin PM, Hamdy NA (2002) A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone 31:556–561PubMedCrossRef Brumsen C, Papapoulos SE, Lentjes EG, Kluin PM, Hamdy NA (2002) A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone 31:556–561PubMedCrossRef
9.
Zurück zum Zitat Fitzpatrick LA, Buzas E, Gagne TJ, Nagy A, Horvath C, Ferencz V, Mester A, Kari B, Ruan M, Falus A, Barsony J (2003) Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci USA 100:6027–6032PubMedCrossRef Fitzpatrick LA, Buzas E, Gagne TJ, Nagy A, Horvath C, Ferencz V, Mester A, Kari B, Ruan M, Falus A, Barsony J (2003) Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci USA 100:6027–6032PubMedCrossRef
10.
Zurück zum Zitat Lippert U, Kruger–Krasagakes S, Moller A, Kiessling U, Czarnetzki BM (1995) Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 4:272–276PubMedCrossRef Lippert U, Kruger–Krasagakes S, Moller A, Kiessling U, Czarnetzki BM (1995) Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 4:272–276PubMedCrossRef
11.
Zurück zum Zitat Vannier E, Dinarello CA (1994) Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. J Biol Chem 269:9952–9956PubMed Vannier E, Dinarello CA (1994) Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. J Biol Chem 269:9952–9956PubMed
12.
Zurück zum Zitat Rasmussen LA, Nielsen HJ, Sorensen S, Sorensen C, Rasmussen R, Sorensen S, Moesgaard F, Larsen J (1995) Ranitidine reduces postoperative interleukin-6 induced C-reactive protein synthesis. J Am Coll Surg 181:138–144PubMed Rasmussen LA, Nielsen HJ, Sorensen S, Sorensen C, Rasmussen R, Sorensen S, Moesgaard F, Larsen J (1995) Ranitidine reduces postoperative interleukin-6 induced C-reactive protein synthesis. J Am Coll Surg 181:138–144PubMed
13.
Zurück zum Zitat Rico H, Gomez M, Revilla M. Gonzalez-Riola J, Seco C, Hernandez ER, Villa LF, Gervas JJ (1999) Effects of promethazine on bone mass and on bone remodeling in ovariectomized rats: A morphometric, densitometric, and histomorphometric experimental study. Calcif Tissue Int 65:272–275PubMedCrossRef Rico H, Gomez M, Revilla M. Gonzalez-Riola J, Seco C, Hernandez ER, Villa LF, Gervas JJ (1999) Effects of promethazine on bone mass and on bone remodeling in ovariectomized rats: A morphometric, densitometric, and histomorphometric experimental study. Calcif Tissue Int 65:272–275PubMedCrossRef
14.
Zurück zum Zitat Lesclous P, Guez D, Saffar JL (2002) Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H2 receptor antagonist cimetidine. Bone 30:131–136PubMedCrossRef Lesclous P, Guez D, Saffar JL (2002) Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H2 receptor antagonist cimetidine. Bone 30:131–136PubMedCrossRef
15.
Zurück zum Zitat Stechschulte DJ, Sharma R, Dileepan KN, Simpson KM, Aggrawal N, Clancy J Jr, Jilka RL (1987) Effect of the mi allele on mast cells, basophils, natural killer cells, and osteoclasts in C57Bl/6J mice. J Cell Physiol 132:565–570CrossRefPubMed Stechschulte DJ, Sharma R, Dileepan KN, Simpson KM, Aggrawal N, Clancy J Jr, Jilka RL (1987) Effect of the mi allele on mast cells, basophils, natural killer cells, and osteoclasts in C57Bl/6J mice. J Cell Physiol 132:565–570CrossRefPubMed
16.
Zurück zum Zitat Lippert U, Moller A, Welker P, Artuc M, Henz BM (2000) Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol 9:118–124CrossRefPubMed Lippert U, Moller A, Welker P, Artuc M, Henz BM (2000) Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol 9:118–124CrossRefPubMed
17.
18.
19.
Zurück zum Zitat Osteoporosis Task Force (2001) American association of clinical endocrinologists. 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 7:293–312 Osteoporosis Task Force (2001) American association of clinical endocrinologists. 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 7:293–312
20.
Zurück zum Zitat McCloskey EV, Spector TD, Eyres KS, Fern ED, O’Rourke N, Vasikaran S, Kanis JA. (1993) The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3:138–147CrossRefPubMed McCloskey EV, Spector TD, Eyres KS, Fern ED, O’Rourke N, Vasikaran S, Kanis JA. (1993) The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3:138–147CrossRefPubMed
21.
Zurück zum Zitat Tangsinmankong N, Bahna SL, Good RA (1999) Osteoporosis for the allergist. Ann Allergy Asthma Immunol 82:5–12PubMedCrossRef Tangsinmankong N, Bahna SL, Good RA (1999) Osteoporosis for the allergist. Ann Allergy Asthma Immunol 82:5–12PubMedCrossRef
22.
Zurück zum Zitat Langhammer A, Norjavaara E, de Verdier MG, Johnsen R, Bjermer L (2004) Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trondelag Health Study (the HUNT Study). Pharmacoepidemiol Drug Saf 13:569–579CrossRefPubMed Langhammer A, Norjavaara E, de Verdier MG, Johnsen R, Bjermer L (2004) Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trondelag Health Study (the HUNT Study). Pharmacoepidemiol Drug Saf 13:569–579CrossRefPubMed
23.
Zurück zum Zitat Fujita K, Kasayama S, Hashimoto J, Nagasaka Y, Nakano N, Morimoto Y, Barnes PJ, Miyatake A (2001) Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res 16:782–787PubMedCrossRef Fujita K, Kasayama S, Hashimoto J, Nagasaka Y, Nakano N, Morimoto Y, Barnes PJ, Miyatake A (2001) Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res 16:782–787PubMedCrossRef
24.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2005) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257:374–384PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L (2005) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257:374–384PubMedCrossRef
25.
Zurück zum Zitat Tyan ML (1993) Effect of promethazine on lumbar vertebral bone mass in postmenopausal women. J Intern Med 234:143–148PubMedCrossRef Tyan ML (1993) Effect of promethazine on lumbar vertebral bone mass in postmenopausal women. J Intern Med 234:143–148PubMedCrossRef
26.
Zurück zum Zitat van Lenthe GH, van den Bergh JP, Hermus AR, Huiskes R (2001) The prospects of estimating trabecular bone tissue properties from the combination of ultrasound, dual-energy X-ray absorptiometry, microcomputed tomography, and microfinite element analysis. J Bone Miner Res 16:550–555PubMedCrossRef van Lenthe GH, van den Bergh JP, Hermus AR, Huiskes R (2001) The prospects of estimating trabecular bone tissue properties from the combination of ultrasound, dual-energy X-ray absorptiometry, microcomputed tomography, and microfinite element analysis. J Bone Miner Res 16:550–555PubMedCrossRef
27.
Zurück zum Zitat Karlsson MK, Duan Y, Ahlborg H, Obrant KJ, Johnell O, Seeman E (2001) Age, gender, and fragility fractures are associated with differences in quantitative ultrasound independent of bone mineral density. Bone 28:118–122CrossRefPubMed Karlsson MK, Duan Y, Ahlborg H, Obrant KJ, Johnell O, Seeman E (2001) Age, gender, and fragility fractures are associated with differences in quantitative ultrasound independent of bone mineral density. Bone 28:118–122CrossRefPubMed
28.
Zurück zum Zitat Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM, for the study of osteoporotic fractures research group (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women: a prospective study. Arch Intern Med 157:629–634CrossRefPubMed Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM, for the study of osteoporotic fractures research group (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women: a prospective study. Arch Intern Med 157:629–634CrossRefPubMed
29.
Zurück zum Zitat Njeh CF, Fuerst T, Diessel E, Genant HK (2001) Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporos Int 12:1–15PubMed Njeh CF, Fuerst T, Diessel E, Genant HK (2001) Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporos Int 12:1–15PubMed
30.
Zurück zum Zitat Hernandez JL, Marin F, Gonzalez-Macias J, Diez-Perez A, Vila J, Gimenez S, Galan B, Arenas MS, Suarez F, Gayola L, Guillen G, Sagredo T, Belenguer R, Moron A, Arriaza E, ECOSAP study investigators (2004) Discriminative capacity of calcaneal quantitative ultrasound and of osteoporosis and fracture risk factors in postmenopausal women with osteoporotic fractures. Calcif Tissue Int 74:357–365CrossRefPubMed Hernandez JL, Marin F, Gonzalez-Macias J, Diez-Perez A, Vila J, Gimenez S, Galan B, Arenas MS, Suarez F, Gayola L, Guillen G, Sagredo T, Belenguer R, Moron A, Arriaza E, ECOSAP study investigators (2004) Discriminative capacity of calcaneal quantitative ultrasound and of osteoporosis and fracture risk factors in postmenopausal women with osteoporotic fractures. Calcif Tissue Int 74:357–365CrossRefPubMed
31.
Zurück zum Zitat Drozdzowska B, Pluskiewicz W (2002) The ability of quantitative ultrasound at the calcaneus to identify postmenopausal women with different types of nontraumatic fractures. Ultrasound Med Biol 28:1491–1497CrossRefPubMed Drozdzowska B, Pluskiewicz W (2002) The ability of quantitative ultrasound at the calcaneus to identify postmenopausal women with different types of nontraumatic fractures. Ultrasound Med Biol 28:1491–1497CrossRefPubMed
32.
Zurück zum Zitat Cepollaro C, Gonnelli S, Rottoli P, Montagnani A, Caffarelli C, Bruni D, Nikiforakis N, Fossi A, Rossi S, Nuti R (2005) Bone ultrasonography in glucocorticoid-induced osteoporosis. Osteoporos Int 16:743–748CrossRefPubMed Cepollaro C, Gonnelli S, Rottoli P, Montagnani A, Caffarelli C, Bruni D, Nikiforakis N, Fossi A, Rossi S, Nuti R (2005) Bone ultrasonography in glucocorticoid-induced osteoporosis. Osteoporos Int 16:743–748CrossRefPubMed
33.
Zurück zum Zitat Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ, for the EPIDOS prospective study group (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348:511–514CrossRefPubMed Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ, for the EPIDOS prospective study group (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348:511–514CrossRefPubMed
34.
Zurück zum Zitat Joakimsen RM, Fonnebo V, Magnus JH, Tollan A, Sogaard AJ (1998) The Tromso Study: body height, body mass index and fractures. Osteoporos Int 8:436–442CrossRefPubMed Joakimsen RM, Fonnebo V, Magnus JH, Tollan A, Sogaard AJ (1998) The Tromso Study: body height, body mass index and fractures. Osteoporos Int 8:436–442CrossRefPubMed
35.
Zurück zum Zitat Broussard DL, Magnus JH (2004) Risk assessment and screening for low bone mineral density in a multi-ethnic population of women and men: does one approach fit all? Osteoporos Int 15:349–360CrossRefPubMed Broussard DL, Magnus JH (2004) Risk assessment and screening for low bone mineral density in a multi-ethnic population of women and men: does one approach fit all? Osteoporos Int 15:349–360CrossRefPubMed
36.
Zurück zum Zitat Akerman MJ, Calacanis CM, Madsen MK (2004) Relationship between asthma severity and obesity. J Asthma 41:521–526PubMedCrossRef Akerman MJ, Calacanis CM, Madsen MK (2004) Relationship between asthma severity and obesity. J Asthma 41:521–526PubMedCrossRef
37.
Zurück zum Zitat Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A (2004) Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol 160:969–976CrossRefPubMed Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A (2004) Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol 160:969–976CrossRefPubMed
38.
Zurück zum Zitat Mai XM, Bottcher MF, Leijon I (2004) Leptin and asthma in overweight children at 12 years of age. Pediatr Allergy Immunol 15:523–530CrossRefPubMed Mai XM, Bottcher MF, Leijon I (2004) Leptin and asthma in overweight children at 12 years of age. Pediatr Allergy Immunol 15:523–530CrossRefPubMed
39.
Metadaten
Titel
Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy
verfasst von
Viktoria Ferencz
Szilvia Meszaros
Emoke Csupor
Edit Toth
Katalin Bors
Andras Falus
Csaba Horvath
Publikationsdatum
01.03.2006
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 3/2006
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-005-0011-z

Weitere Artikel der Ausgabe 3/2006

Osteoporosis International 3/2006 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.